Secondary hyperparathyroidism, vitamin D sufficiency, and serum calcium 5 years after gastric bypass and duodenal switch

Obesity Surgery

Volumn 23, Issue 3, 2013, Pages 384-390

  Hewitt, Stephen ^a   Søvik, Torgeir T ^b,c   Aasheim, Erlend T ^a   Kristinsson, Jon ^a,b   Jahnsen, Jørgen ^a   Birketvedt, Grethe S ^a   Bøhmer, Thomas ^a   Eriksen, Erik F ^a,c   Mala, Tom ^a,b  

^a AKER UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Bariatric surgery; Calcium; Duodenal switch; Gastric bypass; Hypocalcemia; Parathyroid hormone; Secondary hyperparathyroidism; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; CALCIUM ION; COLECALCIFEROL; CREATININE; MAGNESIUM; PARATHYROID HORMONE; PHOSPHATE;

ADULT; ARTICLE; BILIOPANCREATIC BYPASS; CALCIUM BLOOD LEVEL; CLINICAL ASSESSMENT; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; STOMACH BYPASS; SUN EXPOSURE; VITAMIN BLOOD LEVEL;

ADULT; CALCIUM; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DUODENUM; FEMALE; GASTROPLASTY; HUMANS; HYPERPARATHYROIDISM, SECONDARY; MALE; MIDDLE AGED; NORWAY; OBESITY, MORBID; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PREVALENCE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VITAMIN D;

EID: 84875282066     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-012-0772-3     Document Type: Article

References (35)

1. Sjøstrøm L, Narbro K, Sjøstrøm CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;8:741-52.
2. Tucker ON, Szomstein S, Rosenthal RJ. Nutritional consequences of weight-loss surgery. Med Clin N Am. 2007;91:499-514.
3. Ziegler O, Sirveaux MA, Brunaud L, et al. Medical follow-up after bariatric surgery: nutritional and drug issues. General recommendations for the prevention and treatment of nutritional deficiencies. Diabetes Metab. 2009;35:544-57.
4. Mechanick JI, Kushner RF, Sugerman HJ, et al. AACE/TOS/ASMBS guidelines. Obesity. 2009;17:S1-S70.
5. Aasheim ET, Hofsø D, Hjelmesæth J, et al. Vitamin status in morbidly obese patients: a cross-sectional study. Am J Clin Nutr. 2008;87:862-9.
6. Aasheim ET, Björkman S, Søvik TT, et al. Vitamin status after bariatric surgery: a randomised study of gastric bypass and duodenal switch. Am J Clin Nutr. 2009;90:15-22.
7. Gasteyger C, Suter M, Gaillard RC, et al. Nutritional deficiencies after Roux-en-Y gastric bypass for morbid obesity often cannot be prevented by standard multivitamin supplementation. Am J Clin Nutr. 2008;87:1128-33.
8. Søvik TT, Aasheim ET, Taha O, et al. Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch. Ann Intern Med. 2011;155:281-91.
9. DiGiorgi M, Daud A, Inabnet WB, et al. Markers of bone and calcium metabolism following gastric bypass and laparoscopic adjustable gastric banding. Obes Surg. 2008;18:1144-8.
10. Signori C, Zalesin KC, Franklin B, et al. Effect of gastric bypass on vitamin D and secondary hyperparathyroidism. Obes Surg. 2010;20:949-52.
11. Youssef Y, Richards WO, Sekhar N, et al. Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery in obese women. Surg Endosc. 2007;21:1393-6.
12. Clements RH, Yellumahanhi K, Wesley M, et al. Hyperparathyroidism and vitamin D deficiency after laparoscopic gastric bypass. Am Surg. 2008;74(6):469-74.
13. Ybarra J, Sanches-Hernandez J, Gich I, et al. Unchanged hypovitaminosis D and secondary hyperparathyroidism in morbid obesity after bariatric surgery. Obes Surg. 2005;3:330-5.
14. Vilarrasa N, San Jose P, Garcia I, et al. Evaluation of bone mineral density loss in morbidly obese women after gastric bypass: 3-year follow-up. Obes Surg. 2011;21:465-72.
15. Valderas JP, Soledad V, Solari S, et al. Increase of bone resorption and the parathyroid hormone in postmenopausal women in the long-term after Roux-en-Y gastric bypass. Obes Surg. 2009;19:1132-8.
16. Balsa JA, Botella-Carratero JI, Peromingo R, et al. Role of calcium malabsorption in the development of secondary hyperparathyroidism after biliopancreatic diversion. J Endocrinol Invest. 2008;31:845-50.
17. Topart P, Becouarn G, Salle A. Five-year follow-up after biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis. 2011;7:199-205.
18. Johnson JM, Maher JW, DeMaria EJ, et al. The long-term effects of gastric bypass on vitamin D metabolism. Ann Surg. 2006;243:701-5.
19. Compher CW, Badellino K, Boullata JI. Vitamin D and the bariatric surgical patient: a review. Obes Surg. 2008;18:220-4.
20. Hamoui N, Kim K, Anthone G, et al. The significance of elevated levels of parathyroid hormone in patients with morbid obesity before and after bariatric surgery. Arch Surg. 2003;138:891-7.
21. Grethen E, McClintock R, Gupta CE, et al. Vitamin D and hyperparathyroidism in obesity. J Clin Endocrinol Metab. 2011;96:1320-6.
22. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96:53-8.
23. Bischoff-Ferrari HA. Optimal serum 25-OH-hydroxyvitamin D levels for multiple health outcomes. Adv Exp Med Biol. 2008;624:55-71.
24. Goldner WS, Stoner JA, Lyden E, et al. Finding the optimal dose of vitamin D following Roux-en-Y gastric bypass: a prospective, randomized pilot clinical trial. Obes Surg. 2009;19:173-9.
25. Carlin AM, Rao DS, Yager KM, et al. Treatment of vitamin D depletion after Roux-en-Y gastric bypass: a randomized prospective clinical trial. Surg Obes Relat Dis. 2009;5:444-9.
26. Srikanth MS, Quddusi S, Fox SR, et al. Correction of secondary hyperparathyroidism after distal gastric bypass using oral high dose vitamin D, calcitriol and calcium replacement. Surg Obes Relat Dis. 2005;1:271.
27. Nelson ML, Bolduc LM, Toder ME, et al. Correction of preoperative vitamin D deficiency after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2007;3:434-7.
28. Anonymous. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr 1992; 55:615S-619S.
29. Søvik TT, Taha O, Aasheim ET, et al. Randomized clinical trial of laparoscopic gastric bypass versus laparoscopic duodenal switch for superobesity. Br J Surg. 2010;97(2):160-6.
30. Heber D, Greenway FL, Kaplan LM, et al. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95:4823-43.
31. Bøhmer T. Magnesium deficiency. Tidsskr Nor Lægeforen. 1986;106:548-51.
32. Parfitt AM. The hyperparathyroidism of chronic renal failure: a disorder of growth. Kidney Int. 1997;52:3-9.
33. McDuffie LA, Bucher BT, Erwein CR, et al. Intestinal adaptation after small bowel resection in human infants. J Pedatr Surg. 2011;46:1045-51.
34. Tandapu P, Provost D, Adams-Huet B, et al. Comparison of the absorption of calcium carbonate and calcium citrate after Roux-en-Y gastric bypass. Obes Surg. 2009;19:1256-61.
35. Harper J, Madan AK, Ternovits CA, et al. What happens to patients who do not follow-up after bariatric surgery? Am Surg. 2007;73:181-4.